NCT04278768 2026-03-19Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)Curis, Inc.Phase 1/2 Suspended366 enrolled
NCT06454409 2025-11-19Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid LeukemiaCity of Hope Medical CenterPhase 1 Suspended20 enrolled